Randomized phase II trial of radium-223 (RA) plus enzalutamide (EZ) vs. EZ alone in metastatic castration refractory prostate cancer (mCRPC)
Maughan, B.L., Hahn, A., Hoffman, J., Morton, K., Gupta, S., Batten, J., Thorley, J., Hawks, J., Nachaegari, G., Nussenzveig, R., Boucher, K., Agarwal, N.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Prevalence of clinically actionable germline pathogenic variants (PVs) in advanced prostate cancer (aPC)
Hahn, A.W., Kapron, A.L., Boyle, J., Kohlmann, W., Poole, A., Gill, D.M., Greenberg, S., Hale, P., Teerlink, C., Maughan, B.L., Cannon-Albright, L., Agarwal, N., Cooney, K.A.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
943PMolecular characterization of metastatic urothelial carcinoma (mUC) in prior or current smokers (PCS) vs non-smokers (NS)
Sacristan Santos, V, Esther, J, Maughan, B L, Wesolowski, S, Lin, E, Hahn, A, Sirohi, D, Rathi, N, Swami, U, Nussenzveig, R, Agarwal, N
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
825PRandomized phase II trial of radium-223 (RA) plus enzalutamide (EZ) vs. EZ alone in metastatic castration refractory prostate cancer (mCRPC)
Maughan, B L, Hahn, A, Hoffman, J, Morton, K, Gupta, S, Batten, J, Thorley, J, Hawks, J, Nachaegari, G, Nussenzveig, R, Boucher, K, Agarwal, N
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
841PPrevalence of clinically actionable germline pathogenic variants (PVs) in advanced prostate cancer (aPC)
Hahn, A W, Kapron, A L, Boyle, J, Kohlmann, W, Poole, A, Gill, D M, Greenberg, S, Hale, P, Teerlink, C, Maughan, B L, Cannon-Albright, L, Agarwal, N, Cooney, K A
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
845PDCDK12-altered prostate cancer: Clinical features and therapeutic outcomes to standard systemic therapies, PARP inhibitors, and PD1 inhibitors
Antonarakis, E S, Velho, P Isaacsson, Agarwal, N, Santos, V Sacristan, Maughan, B L, Pili, R, Adra, N, Sternberg, C N, Vlachostergios, P J, Tagawa, S T, Bryce, A H, McNatty, A L, Reichert, Z R, Dreicer, R, Sartor, O, Lotan, T L, Hussain, M
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Unclassified renal cell carcinoma: diagnostic difficulties and treatment modalities
Sirohi, Deepika, Smith, Steven C, Agarwal, Neeraj, Maughan, Benjamin L
Published in Research and reports in urology (01.01.2018)
Published in Research and reports in urology (01.01.2018)
Get full text
Journal Article